Now I have sufficient calibration data. Let me construct the final review.

**Bracket from Round 1:** The paper sits most naturally in the 5.5–7.5 band, with the closest topical anchors at 5.67 (MAPE-PPI), 5.80 (PPIformer), 6.00 (LLaPA), and 7.00 (Bioactivity Prediction).

**Narrowing from Round 2:** Compared to the 5.67–6.00 anchors, this paper has a stronger evaluation methodology (prospective STRING v11→v12 vs. standard benchmarks) and more convincing empirical gains. Compared to the 7.00 anchor (Bioactivity Prediction), this paper has a more significant methodological gap (missing ablation that prevents full attribution of the core claim). The paper is stronger than LLaPA (6.00, rejected on data leakage concerns) and MAPE-PPI (5.67, accepted despite concerns). Its weighted strengths (9.26, 9.20) are at the level of 7+ papers, but its two heavy-drag items (inflated claim weight 1.85, missing ablation weight 1.98) are more severe than the concerns in the 7.00 anchor paper. This places the paper at **6.5**.

---

## Summary

This paper introduces the problem of PPI candidate ranking (prioritizing novel interaction candidates for a given target protein based on its known partners) and proposes a two-stage framework: (1) interpretability-guided retrieval that uses predicted contact maps to identify active residue regions from known interactors, then ranks candidates by cosine similarity in embedding space, and (2) re-ranking by integrating complementary signals (structural plausibility, functional annotations, LLM-based semantic similarity). Evaluation on a prospective STRING v11→v12 transition (future interactions unknown at training time) shows substantial improvements over raw PPI probability baselines.

## Strengths

- **Prospective evaluation via STRING v11→v12 transition.** The paper evaluates on a genuinely held-out future database release using only information available in the prior release. This is ecologically valid and directly measures whether computational methods can anticipate interactions that will only be experimentally confirmed later — a significant methodological improvement over standard cross-validation or random-split evaluation common in PPI work.
- **Clear and well-motivated problem formulation.** Reframing PPI from binary classification to candidate ranking directly addresses the experimental validation bottleneck. The distinction between "predicting whether any two proteins interact" and "which novel candidates are most promising given a target's known partners" is conceptually sound and practically meaningful.
- **Large and consistent empirical gains.** Table 1 shows substantial improvements across multiple metrics and cutoffs for both D-SCRIPT and Topsy-Turvy backbones. For D-SCRIPT, Recall@10 rises from 0.0124 to 0.2641 (≈21×), MRR from 0.0340 to 0.1685 (≈5×), and Success@10 reaches 0.1277 — practically meaningful for experimental screening. Improvements are consistent across cutoffs from k=5 to k=500.
- **Systematic exploration of re-ranking signals.** The paper evaluates ten complementary re-ranking strategies spanning sequence-level scores, structural plausibility (SpeedPPI/pDockQ), ontology-based functional similarity, and LLM-based semantic similarity. The pairwise rank-shift analysis (Table 2) provides a useful comparison of their relative contributions, identifying PubMedBERT fine-tuned as a cross-encoder as the strongest signal (75.5–79.7% maintain-or-improve).

## Weaknesses

### Major

- **Inflated "two orders of magnitude" claim.** The abstract (line 25) states "we improve ranking metrics by two orders of magnitude" without qualification, and the conclusion (line 279) says "up to two orders of magnitude." Table 1 shows the largest relative improvement is Topsy-Turvy Recall@10 at ≈94× (0.00117 → 0.1106); most metrics improve by 2–30× (D-SCRIPT MRR: ≈5×; Average Rank: ≈2×; nDCG@10: ≈21×). The headline claim significantly overstates what the data supports. Even the "up to" qualifier in the conclusion does not match the paper's own data. This should be corrected to precise numbers (e.g., "improving Recall@10 by 21× and MRR by 5×").

- **Missing ablation of the core methodological component.** The central claim of Section 4.1 is that focusing on *active residue regions* (derived from predicted contact maps) rather than full embeddings is beneficial for ranking. However, no experiment compares the proposed active-region cosine similarity against a simple full-embedding cosine similarity (using the entire z_k embedding without contact-map-based filtering). Without this ablation, it is unclear whether the improvement over raw interaction scores comes from (a) the shift to embedding-space similarity, (b) the contact-map-based region selection, or (c) the anchoring on known partners. The paper's ability to attribute gains specifically to the "interpretability-guided" component is substantially weakened.

### Minor

- **Re-ranking evaluation limited in scope for end-to-end claims.** The re-ranking analysis (Table 2) operates only on the top-10 candidates from the interpretability-guided retrieval step (2,280 protein-candidate pairs total). This tests whether signals reshuffle an already-filtered high-quality set, but does not answer: (a) whether re-ranking can bring novel interactions from outside the top-10 into top ranks, or (b) whether the same re-ranking signals applied to raw probability baselines would produce similar gains. The conclusion's end-to-end claim ("integrating interpretability-guided retrieval with multi-source re-ranking yields a step change") is only partially supported by this analysis. The pairwise rank-shift analysis is informative as a study of signal complementarity, but an end-to-end comparison (full pipeline vs. baseline + re-ranking) would substantiate the claim.

- **No variance estimates or per-protein performance characterization.** Table 1 reports aggregate retrieval metrics without confidence intervals, standard deviations, or per-protein distributions. Given that proteins vary enormously in their number of known partners, aggregate metrics could mask failures on important subsets (e.g., proteins with very few known partners, which the paper acknowledges as a limitation but does not quantify).

- **Limited discussion of computational cost.** The paper mentions "runtimes in the order of hundreds of hours (Figure 2)" for retrieval. The re-ranking pipeline involves SpeedPPI/AlphaFold2 on potentially thousands of pairs. No total GPU budget is reported, and the practical feasibility for typical labs is noted only briefly. A statement of total compute would help readers assess real-world applicability.

### Trivial

- None that survive filtering.

## Nice-to-Haves

- An ablation comparing active-region cosine similarity vs. full-embedding cosine similarity (the single most informative missing experiment).
- An end-to-end comparison: (interpretability-guided retrieval + PubMedBERT re-ranking) vs. (raw probability baseline + PubMedBERT re-ranking).
- Per-protein variance visualization (e.g., boxplots of MRR or performance stratified by number of known partners).

## Removed Points

These points from the input review were filtered per guidelines:
- **"Threshold for 'highly activated residues' is underspecified."** Experimental details may reside in Appendix A.1, which was stripped by the parser; this cannot be verified against the complete submission.
- **"No characterization of what kind of interactions are new in v12."** Asks the paper to address a question outside its stated scope.
- **"No discussion of failure cases for re-ranking."** A reasonable suggestion but not a core weakness; the paper's focus is overall comparative analysis.
- **"94× improvement in Topsy-Turvy Recall@10 is an artifact."** Dismissive characterization; the metric value is valid even if the baseline denominator is low.
- **Formatting artifacts, duplicated text, parser issues.** These are not author errors.
- **"Re-ranking analysis is largely uninformative."** Overstates the issue; the analysis is informative as a signal complementarity study, though limited for end-to-end claims (captured in Minor weakness above).

## Novel Insights

None beyond the paper's own contributions. The review does not surface an analytical perspective on the method that the paper has not already articulated.

## Suggestions

1. **Correct the "two orders of magnitude" claim** to precise language (e.g., "improving Recall@10 by 21× and MRR by 5× across the evaluated backbones").
2. **Add the full-embedding ablation** for the retrieval step to isolate the contribution of contact-map-based region selection.
3. **Extend the re-ranking evaluation** to an end-to-end comparison: (interpretability-guided retrieval + top re-ranker) vs. (raw probability baseline + same re-ranker).
4. **Report per-protein variance** (e.g., boxplots or performance stratified by known-partner count).
5. **State the total computational budget** (GPU-hours) to help readers assess practical feasibility.

## Score and Decision

**Calibration Anchors (all rounds):**

| Anchor | Path | Avg Score | Round | Itemized? | Comparison |
|--------|------|-----------|-------|-----------|------------|
| MAPE-PPI | itGkF993gz | 5.67 | 1,2 | Yes | Weaker evaluation design (standard benchmark vs. prospective STRING); more significant missing-reference concerns |
| PPIformer | xcMmebCT7s | 5.80 | 2 | Yes | Comparable in mixed quality; this paper has stronger evaluation but similar methodological gaps |
| LLaPA (PPI LLM) | eh1fL0zw8o | 6.00 | 1,2 | Yes | Higher avg score but rejected on data leakage concerns; this paper's evaluation is cleaner |
| Bioactivity Prediction | S8gbnkCgxZ | 7.00 | 2 | Yes | Stronger completeness of contribution (full benchmark + metrics); this paper's missing ablation is a more significant gap |
| GeSubNet | ja4rpheN2n | 8.00 | 1,2 | Yes | Unanimous accept; this paper is clearly below this level of methodological rigor |
| DeepSSInter | wCwz1F8qY8 | 5.00 | 1 | Yes | Lower quality; mixed reviews, novelty concerns |
| PEEP (enzyme prediction) | 760br3YEtY | 5.60 | 1,2 | No | Lower quality; consistent moderate scores |
| Various strong rejects (fin. markets, etc.) | — | 1.00 | 1 | No | Irrelevant to this paper's quality |

**Final Score Determination:** Round 1 bracket: 5.5–7.5. The paper's highest-weight strengths (prospective evaluation weight 9.26, empirical gains weight 9.20) are comparable to the strongest items in the 7.00 anchor. However, its heaviest-drag items (inflated claim weight 1.85, missing ablation weight 1.98) are more severe than those in the 7.00 anchor and keep the paper below that level. The paper clearly exceeds the 5.67–6.00 anchors (MAPE-PPI, PPIformer) in evaluation rigor and contribution clarity. Narrowing: 6.5.

**Score:** 6.5

**Decision:** Accept

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>